Otsuka Pakistan Limited was incorporated in February 1988 and commenced the commercial production of Intravenous Solutions in September 1989 at its factory located at Hub, Baluchistan. Otsuka Pakistan is an indirect subsidiary of Otsuka Pharmaceutical company Japan, a multinational pharmaceutical company, that completed 100 years of dedication towards improving healthcare around the world in the year 2021. Otsuka Pakistan has been supplying world-class quality products to the Pakistani population which are the number one choice of clinicians in Pakistan. Otsuka Pakistan Limited is dealing mainly in IV solutions and has a wide range of Electrolytes Solutions, Carbohydrates Solutions, and Clinical Nutrition products.
Otsuka - people creating new products for better health worldwide.
To provide quality health care products while maintaining leadership position in chosen segment by working efficiently towards customer satisfaction, rapid growth, and enhanced stakeholders’ value.
We are thrilled to announce the handover of brand-new 𝗦𝘂𝘇𝘂𝗸𝗶 𝗔𝗹𝘁𝗼 𝗩𝗫𝗥 cars to our 𝗙𝗶𝗲𝗹𝗱 𝗠𝗮𝗻𝗮𝗴𝗲𝗿𝘀 as part of our 𝗻𝗲𝘄𝗹𝘆 𝗶𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝗲𝗱 𝗖𝗼𝗺𝗽𝗮𝗻𝘆’𝘀 𝗖𝗮𝗿 𝗣𝗼𝗹𝗶𝗰𝘆!
OPL Quarter I - 2025 Cycle Meeting
We are delighted to announce the handing over of brand-new Suzuki Alto VXR car units to our Senior Field Managers, Field Mangers, and Sr. Deputy Manager upon their promotions, as part of our newly introduced Company Car Policy.
We are delighted to share the news that Otsuka Pakistan Ltd. handed over brand-new units of 𝗞𝗜𝗔 𝗣𝗜𝗖𝗔𝗡𝗧𝗢–𝟮𝟬𝟮𝟱 cars to newly promoted 𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗦𝗮𝗹𝗲𝘀 𝗠𝗮𝗻𝗮𝗴𝗲𝗿𝘀 after induction of the new Company’s car policy.
Annual Kick-Off Meeting 2025
Fatolip Launch
Introducing Our New OPL In-House Gym!
Celebrating the King of Fruits!
Azadi Day celebration
Breast Cancer Awareness
The shareholders’ factory visit had been performed successfully on Tuesday, January 23, 2018
ACCA Approved Employer 2017 –Trainee Development, Gold for Otsuka Pakistan Limited
By striving to think differently, by challenging established ways of thinking, and by exploring paths of discovery that nobody else has thought of, Otsuka will continue to push the
OPL Launched Mucosta (Rebamipide) 100mg tablets - anti-gastritis and anti-gastric ulcer agent in Pakistan
Otsuka launches new molecule in Gastroenterology segment for Gastritis and Gastric Ulcers
Mrs Navin Salim Merchant, Independent Director of the company has successfully completed her SECP approved Director Training Program from December 10th to 13th 2019
Nutraceutical Plant - Inauguration 15, March 2023
Re-opening of Line-II production after successful installation of machinery w.e.f. July 10, 2023
We Welcome Mr. Moin ur Rehman as the Company’s new CEO effective from 28th February 2024
When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies... More information
